Appeal 2007-2649 Application 10/235,998 chloride compound as disclosed by Platt et al in order to improve accuracy of the ECG signal.” (Answer 8-9). Appellants argue that claim 24 is “allowable as depending on allowable claim 20” (Br. 14). Appellants argue that because Platt’s electrodes are separate from the Platt’s closest component analogous to a patient data monitor, Platt does not cure the other references’ failure to “to teach or fairly suggest the use of an electrode patch on a patient data monitor surface” (id.). These arguments are addressed above with respect to claims 11 and 20. We affirm the Examiner’s obviousness rejection of claim 24. SUMMARY We affirm all of the rejections on appeal. We designate the affirmances with respect to claims 3, 4, and 11 only as new grounds of rejection. TIME PERIOD FOR RESPONSE Regarding the affirmed rejection(s), 37 CFR § 41.52(a)(1) provides that “Appellant may file a single request for rehearing within two months from the date of the original decision of the Board.” In addition to affirming the examiner's rejection(s) of one or more claims, this decision contains a new ground of rejection pursuant to 37 CFR § 41.50(b) (effective September 13, 2004, 69 Fed. Reg. 49960 (August 12, 2004), 1286 Off. Gaz. Pat. Office 21 (September 7, 2004)). 37 CFR § 41.50(b) provides: “A new ground of rejection pursuant to this paragraph shall not be considered final for judicial review.” 23Page: Previous 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Next
Last modified: September 9, 2013